---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-028954"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:37:12.009901+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# MindMed holds Analyst Day focused on MM-120 for GAD; no specific data disclosed

## Summary
- Analyst Day held June 20, 2023 in New York, NY.
- Presentation centered on MM-120 program for generalized anxiety disorder (GAD).
- Exhibit 99.1 filed but contains only cover page; substantive slides not included.
- No clinical results, financial guidance, or milestones announced in the filing.

## SEC filing metadata
- accession: 0000950170-23-028954
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000095017023028954/0000950170-23-028954-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000095017023028954/mnmd-20230620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-028954
- JSON: https://secwatch.observer/filing/0000950170-23-028954.json
- Plain text: https://secwatch.observer/filing/0000950170-23-028954.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.